nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—acquired immunodeficiency syndrome	0.749	1	CbGaD
Plerixafor—CXCR4—Binding and entry of HIV virion—CCR5—acquired immunodeficiency syndrome	0.00982	0.117	CbGpPWpGaD
Plerixafor—CXCR4—endothelium—acquired immunodeficiency syndrome	0.00804	0.181	CbGeAlD
Plerixafor—CXCR4—blood plasma—acquired immunodeficiency syndrome	0.00714	0.161	CbGeAlD
Plerixafor—CXCR4—Binding and entry of HIV virion—CD4—acquired immunodeficiency syndrome	0.00616	0.0734	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL3L1—acquired immunodeficiency syndrome	0.00545	0.0649	CbGpPWpGaD
Plerixafor—CXCR4—retina—acquired immunodeficiency syndrome	0.00391	0.0882	CbGeAlD
Plerixafor—CXCR4—Early Phase of HIV Life Cycle—CCR5—acquired immunodeficiency syndrome	0.0036	0.0429	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL4—acquired immunodeficiency syndrome	0.00299	0.0356	CbGpPWpGaD
Plerixafor—CXCR4—lymphoid tissue—acquired immunodeficiency syndrome	0.00278	0.0627	CbGeAlD
Plerixafor—CXCR4—digestive system—acquired immunodeficiency syndrome	0.00275	0.0619	CbGeAlD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.00271	0.0323	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.00264	0.0315	CbGpPWpGaD
Plerixafor—CXCR4—blood—acquired immunodeficiency syndrome	0.00262	0.059	CbGeAlD
Plerixafor—CXCR4—bone marrow—acquired immunodeficiency syndrome	0.00253	0.0571	CbGeAlD
Plerixafor—CXCR4—spinal cord—acquired immunodeficiency syndrome	0.00252	0.0568	CbGeAlD
Plerixafor—CXCR4—vagina—acquired immunodeficiency syndrome	0.00243	0.0547	CbGeAlD
Plerixafor—CXCR4—lung—acquired immunodeficiency syndrome	0.00229	0.0517	CbGeAlD
Plerixafor—CXCR4—Early Phase of HIV Life Cycle—CD4—acquired immunodeficiency syndrome	0.00226	0.027	CbGpPWpGaD
Plerixafor—CXCR4—nervous system—acquired immunodeficiency syndrome	0.00212	0.0479	CbGeAlD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—CCL5—acquired immunodeficiency syndrome	0.00206	0.0246	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00205	0.0244	CbGpPWpGaD
Plerixafor—CXCR4—central nervous system—acquired immunodeficiency syndrome	0.00205	0.0461	CbGeAlD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL3—acquired immunodeficiency syndrome	0.00204	0.0243	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCR2—acquired immunodeficiency syndrome	0.00184	0.022	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CXCL12—acquired immunodeficiency syndrome	0.00173	0.0207	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—CSF2—acquired immunodeficiency syndrome	0.0017	0.0203	CbGpPWpGaD
Plerixafor—CXCR4—brain—acquired immunodeficiency syndrome	0.00162	0.0366	CbGeAlD
Plerixafor—CXCR4—HIV Life Cycle—CCNT1—acquired immunodeficiency syndrome	0.00162	0.0193	CbGpPWpGaD
Plerixafor—CXCR4—lymph node—acquired immunodeficiency syndrome	0.00157	0.0354	CbGeAlD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.00152	0.0181	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00148	0.0176	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00138	0.0164	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL5—acquired immunodeficiency syndrome	0.00132	0.0157	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—APOBEC3G—acquired immunodeficiency syndrome	0.00132	0.0157	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.00125	0.0149	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00124	0.0148	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCR5—acquired immunodeficiency syndrome	0.00119	0.0142	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00112	0.0134	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—CCNT1—acquired immunodeficiency syndrome	0.00112	0.0134	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00105	0.0125	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000951	0.0113	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000833	0.00993	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000768	0.00914	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000754	0.00898	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000694	0.00827	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000653	0.00777	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000635	0.00756	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000586	0.00697	CbGpPWpGaD
Plerixafor—CXCR4—HIV Life Cycle—CCR5—acquired immunodeficiency syndrome	0.000584	0.00696	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000574	0.00684	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000551	0.00656	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000543	0.00647	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.00054	0.00643	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000537	0.0064	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—acquired immunodeficiency syndrome	0.000528	0.00629	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000515	0.00613	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000496	0.00591	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000466	0.00555	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000447	0.00533	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000438	0.00521	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000419	0.00499	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—CCR5—acquired immunodeficiency syndrome	0.000404	0.00481	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000392	0.00467	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000377	0.00449	CbGpPWpGaD
Plerixafor—CXCR4—HIV Life Cycle—CD4—acquired immunodeficiency syndrome	0.000367	0.00437	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000355	0.00422	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00035	0.00417	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000333	0.00397	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000333	0.00397	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000326	0.00388	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000323	0.00385	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000318	0.00378	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.0003	0.00357	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000295	0.00351	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CCNT1—acquired immunodeficiency syndrome	0.000275	0.00327	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000254	0.00302	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—CD4—acquired immunodeficiency syndrome	0.000253	0.00302	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000228	0.00272	CbGpPWpGaD
Plerixafor—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.00171	CcSEcCtD
Plerixafor—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000209	0.0017	CcSEcCtD
Plerixafor—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000208	0.0017	CcSEcCtD
Plerixafor—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.00169	CcSEcCtD
Plerixafor—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.00169	CcSEcCtD
Plerixafor—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000206	0.00167	CcSEcCtD
Plerixafor—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.00167	CcSEcCtD
Plerixafor—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000205	0.00167	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.00167	CcSEcCtD
Plerixafor—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.00166	CcSEcCtD
Plerixafor—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.00166	CcSEcCtD
Plerixafor—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.00166	CcSEcCtD
Plerixafor—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.00166	CcSEcCtD
Plerixafor—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.00166	CcSEcCtD
Plerixafor—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000203	0.00165	CcSEcCtD
Plerixafor—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000203	0.00165	CcSEcCtD
Plerixafor—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000203	0.00165	CcSEcCtD
Plerixafor—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.00165	CcSEcCtD
Plerixafor—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.00165	CcSEcCtD
Plerixafor—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.00164	CcSEcCtD
Plerixafor—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000202	0.00164	CcSEcCtD
Plerixafor—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.00164	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000201	0.0024	CbGpPWpGaD
Plerixafor—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000201	0.00164	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000201	0.00164	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.0002	0.00239	CbGpPWpGaD
Plerixafor—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.0002	0.00163	CcSEcCtD
Plerixafor—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.0002	0.00163	CcSEcCtD
Plerixafor—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.0002	0.00162	CcSEcCtD
Plerixafor—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.00162	CcSEcCtD
Plerixafor—Rash—Didanosine—acquired immunodeficiency syndrome	0.000198	0.00161	CcSEcCtD
Plerixafor—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000198	0.00161	CcSEcCtD
Plerixafor—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000198	0.00161	CcSEcCtD
Plerixafor—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000198	0.00161	CcSEcCtD
Plerixafor—Headache—Didanosine—acquired immunodeficiency syndrome	0.000197	0.0016	CcSEcCtD
Plerixafor—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000197	0.0016	CcSEcCtD
Plerixafor—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000196	0.0016	CcSEcCtD
Plerixafor—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.0016	CcSEcCtD
Plerixafor—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.0016	CcSEcCtD
Plerixafor—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000196	0.00159	CcSEcCtD
Plerixafor—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000195	0.00159	CcSEcCtD
Plerixafor—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.00159	CcSEcCtD
Plerixafor—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000194	0.00158	CcSEcCtD
Plerixafor—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000194	0.00158	CcSEcCtD
Plerixafor—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.00158	CcSEcCtD
Plerixafor—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000194	0.00158	CcSEcCtD
Plerixafor—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000193	0.00157	CcSEcCtD
Plerixafor—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000193	0.00157	CcSEcCtD
Plerixafor—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000193	0.00157	CcSEcCtD
Plerixafor—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.00157	CcSEcCtD
Plerixafor—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.00157	CcSEcCtD
Plerixafor—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.00157	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000192	0.00229	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000192	0.00229	CbGpPWpGaD
Plerixafor—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.00156	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.00156	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00019	0.00155	CcSEcCtD
Plerixafor—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00019	0.00155	CcSEcCtD
Plerixafor—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00019	0.00155	CcSEcCtD
Plerixafor—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.00155	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.00155	CcSEcCtD
Plerixafor—Pain—Indinavir—acquired immunodeficiency syndrome	0.000189	0.00154	CcSEcCtD
Plerixafor—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000189	0.00154	CcSEcCtD
Plerixafor—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.00153	CcSEcCtD
Plerixafor—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000188	0.00153	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000188	0.00224	CbGpPWpGaD
Plerixafor—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.00153	CcSEcCtD
Plerixafor—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000188	0.00153	CcSEcCtD
Plerixafor—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000187	0.00152	CcSEcCtD
Plerixafor—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000187	0.00152	CcSEcCtD
Plerixafor—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.00152	CcSEcCtD
Plerixafor—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000187	0.00152	CcSEcCtD
Plerixafor—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000187	0.00152	CcSEcCtD
Plerixafor—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.00151	CcSEcCtD
Plerixafor—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000186	0.00151	CcSEcCtD
Plerixafor—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.00151	CcSEcCtD
Plerixafor—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000184	0.0015	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.0015	CcSEcCtD
Plerixafor—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000183	0.00149	CcSEcCtD
Plerixafor—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.00149	CcSEcCtD
Plerixafor—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.00148	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000182	0.00217	CbGpPWpGaD
Plerixafor—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000182	0.00148	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.00148	CcSEcCtD
Plerixafor—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.00148	CcSEcCtD
Plerixafor—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.00147	CcSEcCtD
Plerixafor—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000181	0.00147	CcSEcCtD
Plerixafor—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.00147	CcSEcCtD
Plerixafor—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00018	0.00147	CcSEcCtD
Plerixafor—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00018	0.00147	CcSEcCtD
Plerixafor—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.00147	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.00146	CcSEcCtD
Plerixafor—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00018	0.00146	CcSEcCtD
Plerixafor—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.00146	CcSEcCtD
Plerixafor—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.00146	CcSEcCtD
Plerixafor—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.00146	CcSEcCtD
Plerixafor—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.00145	CcSEcCtD
Plerixafor—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.00145	CcSEcCtD
Plerixafor—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.00145	CcSEcCtD
Plerixafor—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000178	0.00145	CcSEcCtD
Plerixafor—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000178	0.00145	CcSEcCtD
Plerixafor—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.00145	CcSEcCtD
Plerixafor—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000178	0.00145	CcSEcCtD
Plerixafor—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000177	0.00144	CcSEcCtD
Plerixafor—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.00144	CcSEcCtD
Plerixafor—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.00143	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.00143	CcSEcCtD
Plerixafor—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000175	0.00143	CcSEcCtD
Plerixafor—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.00142	CcSEcCtD
Plerixafor—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.00142	CcSEcCtD
Plerixafor—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000174	0.00142	CcSEcCtD
Plerixafor—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.00142	CcSEcCtD
Plerixafor—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000174	0.00142	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000174	0.00207	CbGpPWpGaD
Plerixafor—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000174	0.00141	CcSEcCtD
Plerixafor—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.00141	CcSEcCtD
Plerixafor—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000173	0.00141	CcSEcCtD
Plerixafor—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000172	0.0014	CcSEcCtD
Plerixafor—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.0014	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.0014	CcSEcCtD
Plerixafor—Rash—Stavudine—acquired immunodeficiency syndrome	0.000172	0.0014	CcSEcCtD
Plerixafor—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.0014	CcSEcCtD
Plerixafor—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000172	0.0014	CcSEcCtD
Plerixafor—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000172	0.0014	CcSEcCtD
Plerixafor—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.0014	CcSEcCtD
Plerixafor—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000172	0.0014	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000171	0.00204	CbGpPWpGaD
Plerixafor—Headache—Stavudine—acquired immunodeficiency syndrome	0.000171	0.00139	CcSEcCtD
Plerixafor—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000171	0.00139	CcSEcCtD
Plerixafor—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.00139	CcSEcCtD
Plerixafor—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.00139	CcSEcCtD
Plerixafor—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.00139	CcSEcCtD
Plerixafor—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00017	0.00139	CcSEcCtD
Plerixafor—Rash—Abacavir—acquired immunodeficiency syndrome	0.00017	0.00138	CcSEcCtD
Plerixafor—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000169	0.00138	CcSEcCtD
Plerixafor—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.00138	CcSEcCtD
Plerixafor—Headache—Abacavir—acquired immunodeficiency syndrome	0.000168	0.00137	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.00137	CcSEcCtD
Plerixafor—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000168	0.00137	CcSEcCtD
Plerixafor—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000168	0.00137	CcSEcCtD
Plerixafor—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.00136	CcSEcCtD
Plerixafor—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.00136	CcSEcCtD
Plerixafor—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.00135	CcSEcCtD
Plerixafor—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.00135	CcSEcCtD
Plerixafor—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.00135	CcSEcCtD
Plerixafor—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.00134	CcSEcCtD
Plerixafor—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.00134	CcSEcCtD
Plerixafor—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.00134	CcSEcCtD
Plerixafor—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.00134	CcSEcCtD
Plerixafor—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.00133	CcSEcCtD
Plerixafor—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.00133	CcSEcCtD
Plerixafor—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000163	0.00132	CcSEcCtD
Plerixafor—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000163	0.00132	CcSEcCtD
Plerixafor—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.00132	CcSEcCtD
Plerixafor—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000162	0.00132	CcSEcCtD
Plerixafor—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000162	0.00132	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.00132	CcSEcCtD
Plerixafor—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.00131	CcSEcCtD
Plerixafor—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00016	0.0013	CcSEcCtD
Plerixafor—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.0013	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.0013	CcSEcCtD
Plerixafor—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.00129	CcSEcCtD
Plerixafor—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.00129	CcSEcCtD
Plerixafor—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000158	0.00129	CcSEcCtD
Plerixafor—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.00129	CcSEcCtD
Plerixafor—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.00128	CcSEcCtD
Plerixafor—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.00128	CcSEcCtD
Plerixafor—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.00128	CcSEcCtD
Plerixafor—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000157	0.00128	CcSEcCtD
Plerixafor—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.00127	CcSEcCtD
Plerixafor—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000156	0.00127	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.00126	CcSEcCtD
Plerixafor—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.00125	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.00125	CcSEcCtD
Plerixafor—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.00125	CcSEcCtD
Plerixafor—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.00125	CcSEcCtD
Plerixafor—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.00124	CcSEcCtD
Plerixafor—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.00124	CcSEcCtD
Plerixafor—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.00124	CcSEcCtD
Plerixafor—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.00124	CcSEcCtD
Plerixafor—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.00123	CcSEcCtD
Plerixafor—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000151	0.00123	CcSEcCtD
Plerixafor—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000151	0.00123	CcSEcCtD
Plerixafor—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.00123	CcSEcCtD
Plerixafor—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00015	0.00122	CcSEcCtD
Plerixafor—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.00122	CcSEcCtD
Plerixafor—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.00122	CcSEcCtD
Plerixafor—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.00121	CcSEcCtD
Plerixafor—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.00121	CcSEcCtD
Plerixafor—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.0012	CcSEcCtD
Plerixafor—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.0012	CcSEcCtD
Plerixafor—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.00119	CcSEcCtD
Plerixafor—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.00119	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.00119	CcSEcCtD
Plerixafor—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.00119	CcSEcCtD
Plerixafor—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000146	0.00119	CcSEcCtD
Plerixafor—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.00119	CcSEcCtD
Plerixafor—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.00118	CcSEcCtD
Plerixafor—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.00118	CcSEcCtD
Plerixafor—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.00118	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000143	0.00171	CbGpPWpGaD
Plerixafor—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.00116	CcSEcCtD
Plerixafor—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.00116	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000141	0.00168	CbGpPWpGaD
Plerixafor—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.00115	CcSEcCtD
Plerixafor—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.00115	CcSEcCtD
Plerixafor—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000141	0.00115	CcSEcCtD
Plerixafor—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.00114	CcSEcCtD
Plerixafor—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00014	0.00114	CcSEcCtD
Plerixafor—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.00114	CcSEcCtD
Plerixafor—Rash—Indinavir—acquired immunodeficiency syndrome	0.000139	0.00113	CcSEcCtD
Plerixafor—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000139	0.00113	CcSEcCtD
Plerixafor—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00113	CcSEcCtD
Plerixafor—Headache—Indinavir—acquired immunodeficiency syndrome	0.000138	0.00112	CcSEcCtD
Plerixafor—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.00112	CcSEcCtD
Plerixafor—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.00111	CcSEcCtD
Plerixafor—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.00111	CcSEcCtD
Plerixafor—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.00109	CcSEcCtD
Plerixafor—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.00109	CcSEcCtD
Plerixafor—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.00108	CcSEcCtD
Plerixafor—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.00108	CcSEcCtD
Plerixafor—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.00107	CcSEcCtD
Plerixafor—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.00107	CcSEcCtD
Plerixafor—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.00107	CcSEcCtD
Plerixafor—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000131	0.00107	CcSEcCtD
Plerixafor—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.00106	CcSEcCtD
Plerixafor—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.00106	CcSEcCtD
Plerixafor—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.00106	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00013	0.00155	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000129	0.00154	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000128	0.00153	CbGpPWpGaD
Plerixafor—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.00104	CcSEcCtD
Plerixafor—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.00103	CcSEcCtD
Plerixafor—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.00103	CcSEcCtD
Plerixafor—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.00102	CcSEcCtD
Plerixafor—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.00102	CcSEcCtD
Plerixafor—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.00102	CcSEcCtD
Plerixafor—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.00102	CcSEcCtD
Plerixafor—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.00102	CcSEcCtD
Plerixafor—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.00101	CcSEcCtD
Plerixafor—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000993	CcSEcCtD
Plerixafor—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000989	CcSEcCtD
Plerixafor—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000989	CcSEcCtD
Plerixafor—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000975	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000119	0.00142	CbGpPWpGaD
Plerixafor—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000964	CcSEcCtD
Plerixafor—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000955	CcSEcCtD
Plerixafor—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000954	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000117	0.0014	CbGpPWpGaD
Plerixafor—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000947	CcSEcCtD
Plerixafor—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000946	CcSEcCtD
Plerixafor—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000943	CcSEcCtD
Plerixafor—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.00094	CcSEcCtD
Plerixafor—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000919	CcSEcCtD
Plerixafor—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000911	CcSEcCtD
Plerixafor—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000911	CcSEcCtD
Plerixafor—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.00091	CcSEcCtD
Plerixafor—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000905	CcSEcCtD
Plerixafor—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000892	CcSEcCtD
Plerixafor—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000876	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000107	0.00128	CbGpPWpGaD
Plerixafor—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000869	CcSEcCtD
Plerixafor—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000868	CcSEcCtD
Plerixafor—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000863	CcSEcCtD
Plerixafor—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000858	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000101	0.0012	CbGpPWpGaD
Plerixafor—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000819	CcSEcCtD
Plerixafor—CXCR4—Disease—CCR5—acquired immunodeficiency syndrome	9.89e-05	0.00118	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.69e-05	0.000916	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.57e-05	0.000902	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.46e-05	0.000889	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.93e-05	0.000825	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.77e-05	0.000807	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CD4—acquired immunodeficiency syndrome	6.21e-05	0.00074	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4e-05	0.000477	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.98e-05	0.000474	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6—acquired immunodeficiency syndrome	3.36e-05	0.0004	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.35e-05	0.00028	CbGpPWpGaD
